Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer
Patients with an individualized eGFR <60 ml/min showed significantly higher cisplatin non-completion rates even when their CGCCr was ≥60 ml/min. These findings suggest that individualized eGFR assessment, in addition to CGCCr, should be considered for optimizing cisplatin dosing in cervical cancer CCRT.
Authors
- Yoshitomi Kanemitsu (ORCID: https://orcid.org/0000-0002-0209-224X)
- Munetoshi Sugiura
- Akira TOYAMA
- KENSUKE YOSHIDA
- NAOTO HOSHINO
Institutions
- Tokyo University of Pharmacy and Life Sciences (JP)
- Niigata University Medical and Dental Hospital (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-12-30
- DOI
- https://doi.org/10.21873/anticanres.17941
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00